Rheumatology > Lupus Slow Steroid Tapering Succeeds in SLE — Flare rates were significantly lower with gradual withdrawal than with low-dose maintenance by Nancy Walsh, Contributing Writer ...

Baseline prednisone use is associated with an increased risk for poor outcomes among patients with systemic lupus erythematosus who are tapering hydroxychloroquine, according to data published in ...

Treatment successfully prevented disease flare-ups in 77 percent of patients on the continued prednisone regimen. The same outcome was achieved in 65 percent of patients on the tapering regimen.

At 6 months, 15.5% of participants who completely tapered off prednisone experienced a relapse of GPA compared with 4.2% of those taking low-dose prednisone.

Treatment successfully prevented disease flare-ups in 77 percent of patients on the continued prednisone regimen. The same outcome was achieved in 65 percent of patients on the tapering regimen.

Treatment guidelines for moderate-to-severe BP suggest a starting prednisone dose of 0.5-1.0 mg/kg and a slow taper.

Having no previous experience with the drug, I have no expectation of side effects or what this dose means. Within a couple of days, 80 mg of prednisone daily has turned me into an eating machine with ...

When can I lower my dose of prednisone? After about a month of taking prednisone, your doctor will start to taper down your dose by about 5 to 10 milligrams (mg) a day.

Of the patients who relapsed, six underwent a second prednisone taper for 8 weeks with a mean initial daily dose of 32.1 mg, four regained and maintained remission, and two experienced a second ...

Early glucocorticoid initiation among patients with GCA was associated with a reduced risk for relapse and lower prednisone doses during tapering.

An initial median prednisone dose of 45 mg per day achieved significantly better complete renal response rates at 1 year in patients with new-onset lupus nephritis, according to data published in ...

From baseline to week 52, reductions in the proportion of patients with active manifestations in the avacopan vs prednisone taper groups were 97.3% vs 96.5% (general), 100% vs 93.5% (nervous ...